Reglagene is pleased to announce that we have been selected as one of three finalists!

Breakthrough results in quadruplex science!

Karen Deyo of Life Science Nation interviews Richard about his experience and how he pulled off such an incredible two-day event.

Award enables application of its novel TERT gene-targeting technology to discover and develop a new therapy for GBM.

The RESI Innovation Challenge featured 30 early-stage life science companies from around the world.

Reglagene is among 10 awardees in the Fall 2019 round of the Arizona Innovation Challenge.

We’re delighted to add Sharon Ayd, PhD, MBA to its Board of Directors.

Our tightly woven and compelling presentation also served as the basis for conversations with prospective investors and pharmaceutical partners.